Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Leukemia

Free Subscription 15.07.2024 1 Am J Clin Pathol 3 Am J Hematol 4 Ann Hematol 3 Blood 2 BMC Cancer 1 Bone Marrow Transplant 13 Br J Haematol 1 Cancer Lett 3 Eur J Haematol 1 Int J Hematol 1 J Natl Cancer Inst 3 Leuk Lymphoma 1 Leuk Res 4 Leukemia

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Clin Pathol

1. 
   Correction to: Improved Recognition of Hematogones From Precursor B-Lymphoblastic Leukemia by a Single Tube Flow Cytometric Analysis.
   Am J Clin Pathol. 2024 Jul 6:aqae096. doi: 10.1093.
   PubMed        
   
   

   
   Am J Hematol

2. BALEV M, Zibara V, Van Hyfte G, Feld J, et al
   Evaluating the role of Day 14 bone marrow biopsy and European LeukemiaNet risk classification in predicting overall and relapse-free survival in acute myeloid leukemia.
   Am J Hematol. 2024 Jul 5. doi: 10.1002/ajh.27429.
   PubMed         Abstract available
   
   
3. SMITH CJ, Ruan GJ, Kluck LA, Maberry M, et al
   BCR-ABL testing in the evaluation of neutrophilia.
   Am J Hematol. 2024;99:1651-1654.
   PubMed        
   
   
4. KANTARJIAN HM, Chifotides HT, Haddad FG, Short NJ, et al
   Ponatinib-review of historical development, current status, and future research.
   Am J Hematol. 2024;99:1576-1585.
   PubMed         Abstract available
   
   

   
   Ann Hematol

5. CAO HY, Li HY, Cai WZ, Huang YH, et al
   Genetic and clinical characteristics of acute B-cell lymphoblastic leukemia with MEF2D fusions and report of two novel MEF2D rearrangements.
   Ann Hematol. 2024 Jul 11. doi: 10.1007/s00277-024-05868.
   PubMed         Abstract available
   
   
6. BUDAK B, Tukel EY, Turanli B, Kiraz Y, et al
   Correction to: Integrated systems biology analysis of acute lymphoblastic leukemia: unveiling molecular signatures and drug repurposing opportunities.
   Ann Hematol. 2024 Jul 11. doi: 10.1007/s00277-024-05881.
   PubMed        
   
   
7. LAIMON DN, Sakr DH, Atef B, Shaaban Y, et al
   Highlights of ophthalmological manifestations in newly diagnosed acute leukemia: a correlation with hematological parameters.
   Ann Hematol. 2024 Jul 10. doi: 10.1007/s00277-024-05861.
   PubMed         Abstract available
   
   
8. SINGH S, Lionel S, Jain H, Rajendra A, et al
   Treatment challenges and outcomes of older patients with acute myeloid leukemia from India.
   Ann Hematol. 2024 Jul 8. doi: 10.1007/s00277-024-05873.
   PubMed         Abstract available
   
   

   
   Blood

9. ISSA GC, Stein EM, DiNardo CDD
   How I Treat: Differentiation Therapy in Acute Myeloid Leukemia.
   Blood. 2024 Jul 8:blood.2024024008. doi: 10.1182/blood.2024024008.
   PubMed         Abstract available
   
   
10. HOURIGAN CS
    How complete must an AML remission be?
    Blood. 2024;144:131-132.
    PubMed        
    
    
11. WEI Q, Xu J
    Chronic eosinophilic leukemia with a novel JAK1 mutation responds well to the JAK1/2 inhibitor ruxolitinib.
    Blood. 2024;144:238.
    PubMed        
    
    

    
    BMC Cancer

12. CASILE M, Albrand G, Lahaye C, Lebecque B, et al
    Correction: Value of combining biological age with assessment of individual frailty to optimize management of cancer treated with targeted therapies: model of chronic myeloid leukemia treated with tyrosine kinase inhibitors (BIO-TIMER trial).
    BMC Cancer. 2024;24:806.
    PubMed        
    
    
13. FIFER S, Godsell J, Opat S, Hamad N, et al
    Understanding the experience, treatment preferences and goals of people living with chronic lymphocytic leukemia (CLL) in Australia.
    BMC Cancer. 2024;24:831.
    PubMed         Abstract available
    
    

    
    Bone Marrow Transplant

14. KOO RM, Wong E, Davis JE, Perera T, et al
    A phase 1 dose-escalation study of low-dose lenalidomide maintenance post-allogeneic stem cell transplantation for high-risk acute myeloid leukaemia or myelodysplastic syndrome.
    Bone Marrow Transplant. 2024 Mar 27. doi: 10.1038/s41409-023-02195.
    PubMed        
    
    

    
    Br J Haematol

15. POURHASSAN H, Zhang J, Tinajero J, Pullarkat V, et al
    Therapy-related acute lymphoblastic leukaemia in women with antecedent breast cancer.
    Br J Haematol. 2024;205:158-165.
    PubMed         Abstract available
    
    
16. IYENGAR L, Fong CY, Prakash S, Chong AH, et al
    Cutaneous involvement in chronic lymphocytic leukaemia.
    Br J Haematol. 2024;205:11.
    PubMed        
    
    
17. ZHANG X, Zhong Y, Liu L, Suo S, et al
    MN1::ETV6-positive de novo T-cell acute lymphoblastic leukaemia is sensitive to venetoclax: A case report.
    Br J Haematol. 2024;205:352-355.
    PubMed        
    
    
18. SERAFIN A, Cellini A, Cavarretta CA, Ruocco V, et al
    Exploring the prognostic role of complex karyotype in chronic lymphocytic leukaemia patients treated with venetoclax-based regimens.
    Br J Haematol. 2024;205:189-193.
    PubMed         Abstract available
    
    
19. JEN WY, Kantarjian H, Kadia TM, DiNardo CD, et al
    Combination therapy with novel agents for acute myeloid leukaemia: Insights into treatment of a heterogenous disease.
    Br J Haematol. 2024;205:30-47.
    PubMed         Abstract available
    
    
20. DOURTHE ME, Yakouben K, David A, Thouvenin S, et al
    Success of donor-derived CAR-T cells after failure of autologous CD19 CAR-T cells (tisagenlecleucel) in B-cell acute lymphoblastic leukaemia.
    Br J Haematol. 2024;205:373-377.
    PubMed        
    
    
21. WANG HY, Louis HMS, Costello CL, Murray SS, et al
    A CD10-negative adult B-lymphoblastic leukaemia with amplification of KMT2A without rearrangement: A case report and review of the English literature.
    Br J Haematol. 2024;205:364-367.
    PubMed        
    
    
22. TAURINO G, Dander E, Chiu M, Pozzi G, et al
    Asparagine transport through SLC1A5/ASCT2 and SLC38A5/SNAT5 is essential for BCP-ALL cell survival and a potential therapeutic target.
    Br J Haematol. 2024;205:175-188.
    PubMed         Abstract available
    
    
23. RUPAKUMAR T, Sankar A, Vijayasekharan K, Varikkattu Rajendran P, et al
    Older age, CNS leukaemic involvement and induction tumour lysis increases the risk of methotrexate (MTX)-induced neurotoxicity in childhood acute lymphoblastic leukaemia/lymphoma: Experience from a tertiary care centre in South India.
    Br J Haematol. 2024 May 26. doi: 10.1111/bjh.19559.
    PubMed         Abstract available
    
    
24. PICHLER H, Sedlacek P, Meisel R, Beier R, et al
    Haematopoietic stem cell transplantation after reduced intensity conditioning in children and adolescents with chronic myeloid leukaemia: A prospective multicentre trial of the I-BFM Study Group.
    Br J Haematol. 2024;205:268-279.
    PubMed         Abstract available
    
    
25. JIMENEZ-VICENTE C, Charry P, Castano-Diez S, Guijarro F, et al
    Evaluation of European LeukemiaNet 2022 risk classification in patients undergoing allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: Identification of a very poor prognosis genetic group.
    Br J Haematol. 2024;205:256-267.
    PubMed         Abstract available
    
    
26. RONNACKER J, Urbahn MA, Reicherts C, Kolloch L, et al
    Early blast clearance during sequential conditioning prior to allogeneic stem cell transplantation in patients with acute myeloid leukaemia.
    Br J Haematol. 2024;205:280-290.
    PubMed         Abstract available
    
    
27. ALLEN B, Savoy L, Ryabinin P, Bottomly D, et al
    Upregulation of HOXA3 by isoform-specific Wilms tumour 1 drives chemotherapy resistance in acute myeloid leukaemia.
    Br J Haematol. 2024;205:207-219.
    PubMed         Abstract available
    
    

    
    Cancer Lett

28. YAN N, Wang ZL, Wang XJ, Gale RP, et al
    Measurable residual disease testing by next generation sequencing is more accurate compared with multiparameter flow cytometry in adults with B-cell acute lymphoblastic leukemia.
    Cancer Lett. 2024;598:217104.
    PubMed         Abstract available
    
    

    
    Eur J Haematol

29. GUEUNING C, Lazaro E, Dupuy H, Leonard C, et al
    Characteristics of large granular lymphocyte leukemia associated with variable common immunodeficiency disorders: A study of 12 cases.
    Eur J Haematol. 2024 Jul 10. doi: 10.1111/ejh.14265.
    PubMed         Abstract available
    
    
30. LINES M, Kemper RM, Wallace J, Alexander T, et al
    Use of allopurinol to manage skewed 6-mercaptopurine metabolism in pediatric maintenance acute lymphoblastic leukemia treatment.
    Eur J Haematol. 2024 Jul 11. doi: 10.1111/ejh.14273.
    PubMed         Abstract available
    
    
31. KOCKEROLS C, Valk PJM, Janssen JJWM, Hogenbirk P, et al
    Prediction of sustained remission after tyrosine kinase inhibitor discontinuation with BCR::ABL1 digital PCR in chronic myeloid leukemia patients.
    Eur J Haematol. 2024 Jul 12. doi: 10.1111/ejh.14271.
    PubMed         Abstract available
    
    

    
    Int J Hematol

32. KUROSAWA S, Nakazato T
    Immunohistochemical differentiation of extramedullary acute myeloid leukemia from blastic plasmacytoid dendritic cell neoplasm.
    Int J Hematol. 2024 Jul 10. doi: 10.1007/s12185-024-03817.
    PubMed        
    
    

    
    J Natl Cancer Inst

33. 
    Editor's Note to: Targeting Primitive Chronic Myeloid Leukemia Cells by Effective Inhibition of a New AHI-1-BCR-ABL-JAK2 Complex.
    J Natl Cancer Inst. 2024 Jul 11:djae168. doi: 10.1093.
    PubMed        
    
    

    
    Leuk Lymphoma

34. BORSOI L, Costa F, Milano C, Segantin G, et al
    Elicitation of societal preferences for chronic lymphocytic leukemia's treatments: a discrete choice experiment.
    Leuk Lymphoma. 2024 Jul 9:1-11. doi: 10.1080/10428194.2024.2374041.
    PubMed         Abstract available
    
    
35. HU M, Li J, Hu T, Zhang Z, et al
    Anti-thymocyte globulin combined with post-transplantation cyclophosphamide reduce graft-versus-host disease in hematopoietic stem cell transplantation for pediatric leukemia.
    Leuk Lymphoma. 2024 Jul 7:1-10. doi: 10.1080/10428194.2024.2376179.
    PubMed         Abstract available
    
    
36. DIEBOLD K, Bourne G, Espinoza-Gutarra M, Al-Kadhimi Z, et al
    Idarubicin and cytarabine with and without midostaurin for FLT3-mutated acute myeloid leukemia.
    Leuk Lymphoma. 2024 Jul 7:1-3. doi: 10.1080/10428194.2024.2373324.
    PubMed        
    
    

    
    Leuk Res

37. PARMAR K, Kundu R, Maiti A, Ball S, et al
    Updates in biology, classification, and management of acute myeloid leukemia with antecedent hematologic disorder and therapy related acute myeloid leukemia.
    Leuk Res. 2024;144:107546.
    PubMed         Abstract available
    
    

    
    Leukemia

38. TERASAKI T, Semba Y, Sasaki K, Imanaga H, et al
    The RNA helicases DDX19A/B modulate selinexor sensitivity by regulating MCL1 mRNA nuclear export in leukemia cells.
    Leukemia. 2024 Jul 11. doi: 10.1038/s41375-024-02343.
    PubMed         Abstract available
    
    
39. EFFICACE F, Mahon FX, Richter J, Piciocchi A, et al
    Health-related quality of life and symptoms of chronic myeloid leukemia patients after discontinuation of tyrosine kinase inhibitors: results from the EURO-SKI Trial.
    Leukemia. 2024 Jul 10. doi: 10.1038/s41375-024-02341.
    PubMed         Abstract available
    
    
40. OGBUE O, Kewan T, Bravo-Perez C, Unlu S, et al
    Hemolytic versus malproductive anemia in large granular lymphocytic leukemia.
    Leukemia. 2024 Jul 9. doi: 10.1038/s41375-024-02323.
    PubMed        
    
    
41. KIM H, Tan TK, Lee DZY, Huang XZ, et al
    Oncogenic dependency on SWI/SNF chromatin remodeling factors in T-cell acute lymphoblastic leukemia.
    Leukemia. 2024 Jul 5. doi: 10.1038/s41375-024-02331.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.